Considerations for clinical trial design and data analyses of thorough QT studies using drug-drug interaction.
Zhu
Hao
H
Division of Pharmacometrics, Office of Clinical Pharmacology, CDER, Food and Drug Administration, 10903 New Hampshire Avenue, Room 3150, Building 51, Silver Spring 20993, USA. Hao.Zhu@fda.hhs.gov
Wang
Yaning
Y
Gobburu
Jogarao V
JV
Garnett
Christine E
CE
D002986:Clinical Trials as Topic / Q000379:methods; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*